Guangzhou Baiyunshan Pharmaceutical Holdings (00874) reported a net profit attributable to shareholders of 1.784 billion yuan in the first quarter, a decrease of 2.06% year-on-year.
Baiyunshan (00874) announced that in the first quarter of 2026, it achieved operating revenue of 23.278 billion yuan, an increase of 3.58% year-on-year; net profit attributable to shareholders of the listed company was 1.784 billion yuan, a decrease of 2.06% year-on-year; basic earnings per share were 1.097 yuan.
Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced that in the first quarter of 2026, the operating income was 23.278 billion yuan, an increase of 3.58% year-on-year; the net profit attributable to shareholders of the listed company was 1.784 billion yuan, a decrease of 2.06% year-on-year; and the basic earnings per share were 1.097 yuan.
Related Articles
TSINGTAO BREW (00168) achieved a net profit attributable to the parent of 1.8 billion yuan in the first quarter, a year-on-year increase of 5.2%.
DOBOT Technology's GEM IPO has been accepted, and in 2025, collaboration with Siasun Robot&Automation ranks first in global sales volume.
Alphabet Inc. Class C (GOOGL.US) plans to build the world's first AI park in South Korea, and DeepMind intends to deepen cooperation with Samsung, SK Hynix, LG, and other companies.
TSINGTAO BREW (00168) achieved a net profit attributable to the parent of 1.8 billion yuan in the first quarter, a year-on-year increase of 5.2%.
DOBOT Technology's GEM IPO has been accepted, and in 2025, collaboration with Siasun Robot&Automation ranks first in global sales volume.
Alphabet Inc. Class C (GOOGL.US) plans to build the world's first AI park in South Korea, and DeepMind intends to deepen cooperation with Samsung, SK Hynix, LG, and other companies.
